Novel coronaviruses na cikin jinsin B.COVID-19 cuta ce mai saurin kamuwa da numfashi.Mutane gabaɗaya suna da sauƙi.A halin yanzu, majinyatan da suka kamu da cutar sankara ta coronavirus sune babban tushen kamuwa da cuta;Mutanen da suka kamu da asymptomatic suma suna iya zama tushen kamuwa da cuta.Dangane da binciken cututtukan cututtuka na yanzu, lokacin shiryawa shine kwanaki 1 zuwa 14, galibi daga kwanaki 3 zuwa 7.Babban bayyanar cututtuka sun haɗa da zazzabi, gajiya da bushewar tari.Ana samun cunkoso na hanci, hanci, ciwon makogwaro, myalgia da gudawa a wasu lokuta.
Ana amfani da wannan kit ɗin don gano ingancin in vitro na novel coronavirus 2019-nCov a cikin samfuran numfashi ciki har da swab oropharyngeal, sputum, ruwan lavage na bronchoalveolar da swab nasopharyngeal.An tsara saitin farko da bincike mai alamar FAM don takamaiman gano kwayar halittar ORFlab na 2019-nCov.VIC mai lakabin bincike don N gene na 2019-nCov.Halin halittar RNase P na ɗan adam da aka fitar a lokaci guda tare da samfurin gwajin yana ba da iko na ciki don tabbatar da aikin hakar nucleic da amincin reagent.Binciken da aka yi niyya na ɗan adam RNase P yana da alamar CY5.
Abubuwan da aka gyara | Gwaje-gwaje 50/kit |
RT-PCR Reaction Mix Reagent | 240μL × 1 tube |
Enzyme Mix Reagent | 72μL × 1 tube |
Binciken farko na 2019-nCoV | 48 μL × 1 tube |
Kyakkyawan iko | 200 μL × 1 tube |
Sarrafa mara kyau | 200 μL × 1 tube |
Hankali: 200 kwafi/ml.
Ƙayyadaddun bayanai: Babu giciye tare da SARS-CoV, MERS-CoV, CoV-HKU1, CoV-OC43, CoV-229E, CoV-NL63 da HIN1, H3N2, H5N1, H7N9, mura B, Parainfluenza Virus (123), Rhinovirus(A) ,B,C), Adenovirus (1,2,3,4,5,7,55), Human interstitial pneumovirus, Human metapneumovirus, EBv, cutar kyanda, Human cytomegalic virus, Rota virus, Norovirus, Mumps Virus, Varicella Zoster Virus . neoformans.
Daidaitawa: CV ≤5%.
Tsarin PCR na ainihi: Aehealth Diagenex AL, ABI 7500, ViiATM 7, Quant Studio 7 flex.Roche Lightcycler 480, Agilent Mx3000P/3005P, Rotor-GeneTM6000/0.Bio-Rad CEX96 TouchTM SLAN-96S.SLAN-96P
Ma'aikatarmu tana da tsaftataccen bita na murabba'in murabba'in mita 10,000, ana shigo da kayan aikin masana'anta daga Jamus, kuma an kafa cibiyoyin R&D 5 a duk faɗin ƙasar.
Cibiyar R&D tamu tana da kashi 40% na dukkan ma'aikatan kamfanin, kashi 70% na dukkan ma'aikatan suna da digiri na farko ko sama, kuma 30% suna da digiri na biyu ko sama.
Ta hanyar bincike mai zaman kanta da haɓaka, mahimman fasaha kamar fasahar injiniyan kwayoyin halitta, fasahar shirye-shiryen rigakafin rigakafi guda ɗaya/polyclonal, da ƙananan fasahar haɗaɗɗun ƙwayoyin ƙwayoyin cuta an ƙware, waɗanda za a iya amfani da su don samar da wasu abubuwan da ake buƙata na bioactive da kansu, kafofin watsa labarai na chromatographic, sarrafawa, calibrators da sauran kayan amfanin yau da kullun.
Matsakaicin hanyoyin kula da ingancin kamfani da tsarin gudanarwa mai inganci, daidaitaccen tsarin samar da kayayyaki, dubawar samfuran ƙãre, kulawa da dubawa, tsauraran iko na mahimman matakai.